Cervical Cancer

The Pharmacy Times® Cervical Cancer Resource Center is a comprehensive resource for clinical news and expert insights for the type of cancer that occurs in the cells of the cervix.

Latest News

Female Reproductive System Anatomy - Image credit: mi_viri | stock.adobe.com
FDA Approves Pembrolizumab Plus Chemoradiotherapy to Treat FIGO 2014 Stage III-IVA Cervical Cancer

January 15th 2024

The approval was based on the results of a phase 3 trial that found an improvement in progression-free survival among individuals treated with pembrolizumab.

FDA Accepts sBLA for Tisotumab Vedotin-tftv for the Treatment of Recurrent, Metastatic Cervical Cancer
FDA Accepts sBLA for Tisotumab Vedotin-tftv for the Treatment of Recurrent, Metastatic Cervical Cancer

January 9th 2024

Doctor hand in blue gloves holding influenza vaccine for prevention human.Nurse holding syringe make injection in shoulder of patient in hospital.Covid-19 or coronavirus vaccine - Image credit: Arcyto | stock.adobe.com
Counsel Patients, Parents on the HPV Vaccine

October 19th 2023

FDA US Food and Drug website in browser with company logo, Illustrative Editorial.
FDA Grants Priority Review for Pembrolizumab in Progressive Cervical Cancer

September 21st 2023

Human papillomavirus infection Virus. | Image Credit: Naeblys - stock.adobe.com
Focus on Human Papillomavirus Virus Vaccination in Adults and Young Adults

September 18th 2023

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.